EP3911298
Samsetningar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.1.2020EP published:
15.11.2023EP application number:
20701703.9
EP translation filed:
8.1.2024Grant published:
15.2.2024EPO information:
European Patent Register
Max expiry date:
15.1.2040Expiry date:
15.1.2027Next due date:
31.1.2027
Title in English:
FORMULATIONSLanguage of the patent:
English
Timeline
Today
16.1.2020EP application
15.11.2023EP Publication
8.1.2024Translation submitted
15.2.2024Registration published
15.1.2027Expires
Owner
Name:
Immunocore LimitedAddress:
92 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY, GB
Inventor
Name:
JOHNSON, AndyAddress:
Abingdon Oxfordshire OX14 4RY, GB
Name:
EBNER, MartinAddress:
Abingdon Oxfordshire OX14 4RY, GB
Name:
GRUDZIEN, LukaszAddress:
Abingdon Oxfordshire OX14 4RY, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201900658Date:
17.1.2019Country:
GB
Number:
201905105Date:
10.4.2019Country:
GB
Classification
Categories:
A61K 9/00, A61K 47/12, A61K 47/26, A61K 38/00, A61K 38/17
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.2.2024
Expires: 15.1.2025
Payer: Árnason Faktor ehf.
Number: 6
Paid: 8.1.2025
Expires: 15.1.2026
Payer: Árnason Faktor ehf.
Number: 7
Paid: 13.1.2026
Expires: 15.1.2027
Payer: Árnason Faktor ehf.